Deutsche Bank lowered the firm’s price target on Eli Lilly (LLY) to $900 from $1,010 and keeps a Buy rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- VOO ETF News, 8/11/2025
- Eli Lilly’s Stock Dips Amid Weight-Loss Pill Setback
- IonQ, Eli Lilly, Monster, Crocs, Kratos Trending by Analysts
- Sector Spotlight: Trump administration seeks hometown discount from Big Pharma
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!